Cost information for prescription drugs through an integrated electronic prescribing system

Not Applicable

Completed

• Conditions: ncomplicated hypertension; Circulatory System; Essential (primary) hypertension

• Registration Number: ISRCTN96253624
• Lead Sponsor: McGill University (Université McGill) (Canada)

Brief Summary

2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29321043

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-05-29
• Study Completion: 2016-12-31
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 8733

Inclusion Criteria

1. Male or female subjects, 18 years of age or older
2. Make one or more visits to an enrolled study physician during follow-up
3. Have a diagnosis of uncomplicated hypertension (i.e. hypertension recorded by the study physician in the therapeutic indication field that must be completed with each prescription)
4. No documented diabetes, congestive heart failure, established atherosclerotic disease, peripheral arterial disease, ischaemic heart disease (angina or prior myocardial infarction), past cerebrovascular accident or transient ischaemic attack (TIA), renal disease, asthma, chronic obstructive pulmonary disease (COPD) or left ventricular hypertrophy

Exclusion Criteria

1. Documented diabetes
2. Congestive heart failure
3. Established atherosclerotic disease
4. Peripheral arterial disease
5. Ischaemic heart disease (angina or prior myocardial infarction)

Study & Design

• Study Type: Interventional
• Study Design: Not specified